{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:29:49Z","timestamp":1786984189043,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.ahj.2014.09.015","type":"journal-article","created":{"date-parts":[[2014,11,12]],"date-time":"2014-11-12T05:10:43Z","timestamp":1415769043000},"page":"266-273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Translation of acute coronary syndrome therapies: From evidence to routine clinical practice"],"prefix":"10.1016","volume":"169","author":[{"given":"Martin","family":"Putera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Roark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato D.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Udayakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Califf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bimal R.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2014.09.015_bb0005","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.ahj.2008.07.028","article-title":"Trends in quality of care for patients with acute myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006","volume":"156","author":"Peterson","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2014.09.015_bb0010","first-page":"e82","volume":"110","author":"Antman","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2014.09.015_bb0015","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/CIRCULATIONAHA.107.188209","volume":"117","author":"Antman","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2014.09.015_bb0020","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1161\/CIRCULATIONAHA.109.192663","volume":"120","author":"Kushner","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2014.09.015_bb0025","first-page":"e148","volume":"116","author":"Anderson","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2014.09.015_bb0030","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.jacc.2011.02.009","volume":"57","author":"Wright","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2014.09.015_bb0035","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/01.CIR.82.2.664","volume":"82","author":"Gunnar","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2014.09.015_bb0040","first-page":"1328","article-title":"ACC\/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)","volume":"28","author":"Ryan","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2014.09.015_bb0045","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1161\/01.CIR.100.9.1016","volume":"100","author":"Ryan","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2014.09.015_bb0050","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/01.CIR.102.10.1193","volume":"102","author":"Braunwald","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2014.09.015_bb0055","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1161\/01.CIR.0000030314.11999.6A","volume":"106","author":"Braunwald","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2014.09.015_bb0060","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.ahj.2004.09.013","article-title":"Care of non-ST-segment elevation patients: insights from the CRUSADE national quality improvement initiative","volume":"148","author":"Ohman","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2014.09.015_bb0065","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/CIRCOUTCOMES.108.847145","article-title":"A call to ACTION (acute coronary treatment and intervention outcomes network): a national effort to promote timely clinical feedback and support continuous quality improvement for acute myocardial infarction","volume":"2","author":"Peterson","year":"2009","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ahj.2014.09.015_bb0070","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1136\/hrt.2010.200261","article-title":"The NCDR ACTION Registry\u2013GWTG: transforming contemporary acute myocardial infarction clinical care","volume":"96","author":"Peterson","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2014.09.015_bb0075","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1001\/archinte.166.18.2027","article-title":"Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative","volume":"166","author":"Mehta","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2014.09.015_bb0155","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jama.282.15.1458","article-title":"Why don't physicians follow clinical practice guidelines? A framework for improvement","volume":"282","author":"Cabana","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2014.09.015_bb0160","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/eurheartj\/ehs481","article-title":"Why are we failing to implement effective therapies in cardiovascular disease?","volume":"34","author":"Nieuwlaat","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2014.09.015_bb0165","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta8060","article-title":"Effectiveness and efficiency of guideline dissemination and implementation strategies","volume":"8","author":"Grimshaw","year":"2004","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.ahj.2014.09.015_bb0170","series-title":"The Learning Healthcare System: Workshop Summary","year":"2007"},{"key":"10.1016\/j.ahj.2014.09.015_bb0110","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa050522","article-title":"Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation","volume":"352","author":"Sabatine","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2014.09.015_bb0175","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2014.09.015_bb0180","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2014.09.015_bb0125","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2014.09.015_bb0185","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2014.09.015_bb0190","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","author":"Heart Protection Study Collaborative Group","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2014.09.015_bb0195","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.292.11.1307","article-title":"Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial","volume":"292","author":"de Lemos","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2014.09.015_bb0080","first-page":"57","article-title":"Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group","volume":"2","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2014.09.015_bb0085","first-page":"1115","article-title":"GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2014.09.015_bb0090","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(02)09895-1","article-title":"Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan","volume":"360","author":"Dickstein","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2014.09.015_bb0095","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(03)14282-1","article-title":"Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme","volume":"362","author":"Pfeffer","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2014.09.015_bb0100","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2014.09.015_bb0105","first-page":"349","article-title":"Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group","volume":"2","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2014.09.015_bb0115","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2014.09.015_bb0120","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(96)10452-9","article-title":"Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2014.09.015_bb0130","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJM197711172972004","article-title":"Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction","volume":"297","author":"Chalmers","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2014.09.015_bb0135","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa060898","article-title":"Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction","volume":"354","author":"Antman","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2014.09.015_bb0140","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJM199708143370702","article-title":"A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group","volume":"337","author":"Cohen","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2014.09.015_bb0145","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0140-6736(88)92656-6","article-title":"Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET)","volume":"2","author":"Wilcox","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2014.09.015_bb0150","first-page":"397","article-title":"Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI)","volume":"1","year":"1986","journal-title":"Lancet"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870314006644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870314006644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:52:36Z","timestamp":1757569956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870314006644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0002870314006644"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2014.09.015","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Translation of acute coronary syndrome therapies: From evidence to routine clinical practice","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2014.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}